MedTrace Logo

Gingival Crevicular Fluid Vaspin and Omentin Levels in Type 2 Diabetic Patients With Chronic Periodontitis

NCT02544347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-11-03

No results posted yet for this study

Summary

The aim of the present study were 1) to determine the role of these adipokines in the pathogenesis of periodontal disease, inflammation and tissue destruction comparing with gingival crevicular fluid (GCF) levels of TNF-α, which has a known pro-inflammatory effect in periodontal disease, 2) to investigate the effect of non-surgical periodontal treatment on GCF vaspin and omentin levels in type 2 diabetic (T2DM) patients with Chronic Periodontitis (CP).

Conditions

Interventions

OTHER

gingival crevicular fluid

gingival crevicular fluid was collected

OTHER

non-surgical periodontal treatment

scaling and root planing were performed

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Principal Investigators

  • Umut Ballı, DDS · Bülent Ecevit University Faculty of Dentistry

  • Şeyma Bozkurt Doğan, DDS · Bülent Ecevit University Faculty of Dentistry

  • Figen Öngöz Dede, DDS · Bülent Ecevit University Faculty of Dentistry

  • Erdim Sertoğlu, MD, DDS · Gülhane Military Medical Academy

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-05-31
Completion
2015-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544347 on ClinicalTrials.gov